報價延遲最少15分鐘:2026/03/10 00:31 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
242.59 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
11.03/12.36
|
|
企業價值
618.78B
|
| 資產負債 |
|
每股賬面淨值
33.84
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
94.19B
|
|
每股收益
40.94
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States. |
